Stockreport

United States Wound Biologics Market Insights 2023-2028: with Avita Medical, Organogenesis, Smith+Nephew, Vericel, and Orthofix Dominating [Yahoo! Finance]

Avita Medical, Inc.  (RCEL) 
PDF US wound biologics market was valued at $630.00 million in 2022 and is expected to reach $1,214.92 million with a CAGR of 11.57% during the forecast period. This repo [Read more]